
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Confocal laser endomicroscopy (CLE) is an endoscopic technique designed to produce images of the GI tract's mucosal layer at extremely high magnification and resolution. The foundation of CLE is tissue illumination by low-power laser.
In a nutshell, the laser light is concentrated at a chosen depth in the tissue of interest, and the same lens then refocuses the reflected light onto the detecting device. Only the light that has been refracted through the pinhole upon returning is detected.
Real-time microscopic pictures can be obtained using the probe-based optical technique known as confocal laser endomicroscopy (CLE). Using this high-resolution optical imaging method during cystoscopy may make it possible to grade tumours in real time.
The goal is to validate and modify CLE standards for grading and diagnosing bladder cancer.Using optical fibres, endoscopes produce an image of the interior of the body.
A doctor might implant a bundle of optical fibres into the body. Others reflect light from internal body parts back outward while some transmit light into the body.
Confocal microscopy works on the fundamental premise that the illumination and detection optics are focused on the same diffraction-limited spot, which is moved over the sample to create the whole image on the detector.
The Global confocal laser endomicroscopy system market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The interdisciplinary probe and needle-based confocal laser endomicroscopy platform Cellvizio, developed by Mauna Kea Technologies, today announced the findings of the first clinical trial utilising robotic-assisted bronchoscopy and nCLE in humans.
For the identification of peripheral lung nodules, it combines robotic-assisted bronchoscopy with needle-based confocal laser endomicroscopy using Cellvizio and the MonarchTM Platform from Ethicon 3.
This proved that real-time feedback on proper needle positioning is possible and safe with robotic-assisted bronchoscopic nCLE-imaging in small peripheral lung lesions.Tool-in-nodule confirmation was provided by bronchoscopy with nCLE imaging.
However, corresponding rapid on-site evaluation (ROSE) found no complications and only 9 of 20 patients had representative material confirmed. The needle was adjusted in the patients with the aid of nCLE real-time in vivo cellular imaging feedback to achieve a diagnostic yield across all nodule sizes and locations.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |